From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences.
Department of Pediatrics, Niigata City General Hospital.
Pediatr Infect Dis J. 2021 Jan;40(1):6-10. doi: 10.1097/INF.0000000000002889.
Enterovirus D68 (EV-D68) causes asthma-like respiratory infection in children. Several EV-D68 outbreaks have been reported worldwide since the largest outbreak occurred in the United States in 2014. We experienced an accumulation of pediatric cases with asthma-like respiratory illness in Niigata, Japan, in 2018.
To determine whether EV-D68 was responsible for the case accumulation, this prospective observational study evaluated children hospitalized in 1 of 8 hospitals with asthma-like respiratory illness in Niigata, Japan, during October and November 2018. Diagnoses were made by EV-D68-specific RT-PCR using nasopharyngeal samples. The clade was identified by sequence analyses, and a phylogenetic tree was created. To evaluate seasonal variation, data from pediatric cases with asthma-like respiratory illness in 2018 were retrospectively analyzed.
In 2018, 114 children were hospitalized with asthma-like respiratory illness in October and November, and 47 nasopharyngeal samples were collected. EV-D68 was detected in 22/47 (47%) patients during the study period. The phylogenetic tree revealed that all strains belonged to the clade B3 branch, which has been detected worldwide every 2 years since 2014.
EV-D68 was the associated pathogen for asthma-like respiratory illness in children in Japan in 2018. Clade B3, the dominant clade in outbreaks worldwide, was responsible for the outbreak. Detection and detailed virologic analysis of EV-D68 is important as part of worldwide surveillance, as it will aid in understanding the epidemiologic characteristics of EV-D68 infection.
肠道病毒 D68(EV-D68)可导致儿童出现类似哮喘的呼吸道感染。自 2014 年美国发生最大规模疫情以来,全球已报告多起 EV-D68 疫情。2018 年,日本新潟县积累了多例儿童哮喘样呼吸道疾病病例。
为确定 EV-D68 是否是病例积累的原因,本前瞻性观察性研究评估了 2018 年 10 月至 11 月期间新潟县 8 家医院中因哮喘样呼吸道疾病住院的儿童。通过使用鼻咽样本的 EV-D68 特异性 RT-PCR 进行诊断。通过序列分析确定进化枝,并创建了系统发育树。为评估季节性变化,回顾性分析了 2018 年儿童哮喘样呼吸道疾病的病例数据。
2018 年 10 月至 11 月期间,114 名儿童因哮喘样呼吸道疾病住院,采集了 47 份鼻咽样本。在研究期间,22/47(47%)患者的样本中检测到了 EV-D68。系统发育树显示,所有毒株均属于 2014 年以来每 2 年在全球范围内检测到的 B3 进化枝。
EV-D68 是 2018 年日本儿童哮喘样呼吸道疾病的相关病原体。在全球范围内导致疫情的优势进化枝 B3 在 2014 年以来的每一次疫情中都被检测到。EV-D68 的检测和详细病毒学分析作为全球监测的一部分很重要,因为这有助于了解 EV-D68 感染的流行病学特征。